Navigation Links
Rabies From Transplanted Organ Killed Recipient, CDC Says
Date:3/15/2013

FRIDAY, March 15 (HealthDay News) -- Rabies caused the death of an organ transplant recipient in Maryland, and three other patients who received organs from the same donor are getting anti-rabies shots, government health officials announced Friday.

According to the U.S. Centers for Disease Control and Prevention, the agency and Maryland health officials have confirmed that the patient who died in early March contracted rabies from the donated organ. The transplant was done more than a year ago.

The length of time the patient took to develop rabies symptoms was much longer than the typical rabies incubation period of one to three months, but is consistent with previous reports of long incubation periods, officials said in a statement.

Both the organ donor and the recipient had a raccoon-type rabies virus, according to the CDC's preliminary analysis of tissue samples. This type of rabies infects not only raccoons, but also other wild and domestic animals. In the United States, only one other person is reported to have died from raccoon-type rabies virus.

In 2011, the organ donor became ill, was admitted to a hospital in Florida and then died. The donor's organs, including the kidneys, heart and liver, were transplanted into recipients in Florida, Georgia, Illinois and Maryland.

At the time of the donor's death, rabies was not suspected as the cause and testing for rabies was not performed, the CDC said. Rabies was confirmed as the cause of the donor's death only after the investigation into the Maryland patient's death began.

The donor moved to Florida from North Carolina shortly before becoming ill. Officials are investigating how the donor may have been infected with rabies.

The three other people who received organs from the donor are being evaluated by doctors and are receiving anti-rabies shots. The CDC is working with health officials and health care facilities in Florida, Georgia, Illinois, Maryland and North Carolina to identify people who were in close contact with the donor or the four organ recipients and might require treatment.

The CDC said that, "all potential organ donors in the United States are screened and tested to identify if the donor might present an infectious risk." However, since rabies is now so rare in the United States, "laboratory testing is not routinely performed, as it is difficult for doctors to confirm results in the short window of time they have to keep the organs viable for the recipient," the agency explained.

Typically, only one to three cases of rabies are diagnosed each year in the United States. The disease is most often transmitted through the bite of an infected animal. In the United States, bats, raccoons, skunks and foxes are the most commonly reported rabid animals.

More information

The U.S. Centers for Disease Control and Prevention outlines how to protect your family from rabies.

-- Robert Preidt

SOURCE: U.S. Centers for Disease Control and Prevention, news release, March 15, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Passengers on Bat Plane Cleared of Rabies Risk
2. Untreated Rabies May Not Be Lethal for All, Study Says
3. Genetically modified tobacco plants produce antibodies to treat rabies
4. Giving transplanted cells a nanotech checkup
5. Elsevier organizes label-free technologies conference
6. Discovery could help to develop drugs for organ transplant and cancer patients
7. Scientists tailor cell surface targeting system to hit organelle ZIP codes
8. Mutations impair childhood growth and development by disrupting organization of chromosome pairs
9. 3 types of fetal cells can migrate into maternal organs during pregnancy
10. ACP-New York State Chapter partnership results in patient safety organization recognition
11. Cancers with disorganized traffic systems more difficult to treat: U of A research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rabies From Transplanted Organ Killed Recipient, CDC Says
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... MELBOURNE, Australia , Feb. 21, 2017  IBM (NYSE: ... IBM Watson,s ability to detect abnormalities of the eye,s retina. ... trained a research version of Watson to recognize abnormalities in ... insights and speed in their early identification of patients who ... glaucoma, a leading cause of blindness in the developed world. ...
(Date:2/21/2017)... Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by patients ... having low level of oxygen in their blood ... are to be used only with prescription and ... concentrators work either on rechargeable lithium batteries or ...
(Date:2/21/2017)...   BeyondSpring Pharmaceuticals , a clinical stage ... immuno-oncology cancer therapies, today announced that the Company,s ... 2 trial of BeyondSpring,s innovative lead asset, ... lung cancer (NSCLC) with Docetaxel has been selected ... Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: